Skip to main content
. 2014 Jul 26;6(3):355–366. doi: 10.4252/wjsc.v6.i3.355

Figure 3.

Figure 3

Cardiovascular-related pharmacological therapies which may affect numbers and function of endothelial progenitor cells. TZDs: Thiazolidinedione; DPP4I: Dipeptidyl peptidase 4 inhibitors; ARBs: Angiotensin II receptor blockers; ACEI: Angiotensin converting enzyme inhibitors; CCBs: Calcium channel blockers.